Canasa
Loading...Canasa Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
CANASA® 1000 mg Suppositories are indicated for the treatment of active ulcerative proctitis.
History
There is currently no drug history available for this drug.
Other Information
The active ingredient in CANASA® 1000 mg suppositories is mesalamine, also known as mesalazine or 5-aminosalicylic acid (5-ASA). Chemically, mesalamine is 5-amino-2-hydroxybenzoic acid, and is classified as an anti-inflammatory drug.
The empirical formula is C7H7NO3, representing a molecular weight of 153.14. The structural formula is:
Each CANASA® rectal suppository contains 1000 mg of mesalamine (USP) in a base of Hard Fat, NF.
Sources
Canasa Manufacturers
-
Physicians Total Care, Inc.
![Canasa (Mesalamine) Suppository [Physicians Total Care, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Canasa | Physicians Total Care, Inc.
The usual dosage of CANASA® (mesalamine, USP) 1000 mg suppositories is one rectal suppository 1 time daily at bedtime.
The suppository should be retained for one to three hours or longer, if possible, to achieve the maximum benefit. While the effect of CANASA® suppositories may be seen within three to twenty-one days, the usual course of therapy would be from three to six weeks depending on symptoms and sigmoidoscopic findings. Studies have suggested that CANASA® suppositories will delay relapse after the six-week short-term treatment.
Patient Instructions:NOTE: CANASA® suppositories will cause staining of direct contact surfaces, including but not limited to fabrics, flooring, painted surfaces, marble, granite, vinyl, and enamel.
Detach one suppository from strip of suppositories. Hold suppository upright and carefully remove the plastic wrapper. Avoid excessive handling of suppository, which is designed to melt at body temperature. Insert suppository completely into rectum with gentle pressure, pointed end first. A small amount of lubricating gel may be used on the tip of the suppository to assist insertion. -
Aptalis Pharma Us, Inc.
Canasa | Aptalis Pharma Us Inc
The dosage of CANASA 1000 mg suppositories is one rectal suppository once daily at bedtime.
The suppository should be retained for one to three hours or longer, if possible. The usual course of therapy is from three to six weeks depending on symptoms and sigmoidoscopic findings.
If a patient misses a dose of CANASA, it should be administered as soon as possible, unless it is almost time for next dose. Patients should not use two CANASA suppositories at the same time to make up for a missed dose.
![Canasa (Mesalamine) Suppository [Aptalis Pharma Us, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=89d91601-152b-4398-bebe-af1c023e9935&name=can01-0000-02.jpg)
Login To Your Free Account